🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Human Papillomavirus Infection

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) NCT06075264Phase 25 sites📍 Fort Myers📍 Indianapolis📍 Cleveland Frantz Viral Therapeutics, LLC · Tests: Artesunate ointment, Placebo ointment Prevalence and Clinical Implications of HPV Infection in Male IBD Patients NCT05911750n/a1 site📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… · Tests: Anal pap smear and oral swab for cytology and HPV testing Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India NCT07209917NA4 sites📍 Bangalore📍 Bangalore📍 Bangalore University of California, Irvine · Tests: SAKHI HPV Intervention, Enhanced Standard of Care (SOC+) Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus NCT05918510n/a1 site📍 Rome Regina Elena Cancer Institute · Tests: Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years NCT06756269Phase 21 site📍 Nanning Shanghai Bovax Biotechnology Co., Ltd. · Tests: Medium dose for 15-HPV vaccine, High dose for 15-HPV vaccine, Placebo, 9-HPV vaccine A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV NCT05495906Phase 410 sites📍 Surrey📍 Vancouver📍 Winnipeg University of British Columbia · Tests: Nonavalent HPV vaccine Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation NCT06793410Phase 25 sites📍 Lund📍 Stockholm📍 Uppsala Vastra Gotaland Region · Tests: Early start post-transplant vaccination with Gardasil 9®, Late post-transplant vaccination with Gardasil 9® Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) NCT05672927Phase 41 site📍 Galveston The University of Texas Medical Branch, Galveston · Tests: 9-valent HPV vaccine, 2 doses alternate timing, 9-valent HPV vaccine, 3 doses standard timing Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine NCT07275333NA1 site📍 Zaporizhzhya Karolinska Institutet · Tests: HPV Self-Sampling Kit A Clinical Study of V503 in Chinese Females Who Have Previously Received a Bivalent Human Papillomavirus (HPV) Vaccine (V503-108) NCT07785843Phase 31 site📍 Taizhou Merck Sharp & Dohme LLC · Tests: V503, Placebo A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV) NCT05334706Phase 41 site📍 L'Hospitalet de Llobregat Miquel Angel Pavon Ribas · Tests: Nonavalent HPV vaccine (9vHPV/Gardasil-9™). Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV NCT05266898Phase 41 site📍 New Orleans Louisiana State University Health Sciences Center in New Or… · Tests: Human papillomavirus 9-valent vaccine, recombinant, human papillomavirus vaccine, recombinant Characteristics of Human Papillomavirus (HPV) Infections and HPV Vaccine Attitudes Among Slovenian Women After the Introduction of HPV Vaccination NCT06995157NA1 site📍 Ljubljana University Medical Centre Ljubljana · Tests: Offering HPV vaccine Impact of an e-Bug Educational Intervention on HPV Vaccine Uptake in Middle School Students NCT07266857n/a1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: Consent for HPV vaccination Zopa Retreatment and Vector Shedding in Adults With RRP NCT06538480Phase 43 sites📍 Atlanta📍 Bethesda📍 Cincinnati Precigen, Inc · Tests: Zopapogene imadenovec (Zopa) Risk of Cervical Cancer Following Incident, Persistent and History-unknown HPV Detection NCT07850128n/a1 site📍 Stockholm Karolinska Institutet · Tests: No Intervention: Observational Cohort A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV) NCT07601074Phase 210 sites📍 Phoenix📍 Tucson📍 Little Rock Daré Bioscience, Inc. · Tests: Lopinavir / ritonavir Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts NCT05625633Phase 2, Phase 32 sites📍 Salt Lake City📍 Salt Lake City Western Institute for Veterans Research · Tests: Human Papillomavirus 9-valent Vaccine, Recombinant, Normal Saline Self-sampling for Non-attenders to Cervical Cancer Screening NCT04226313NA1 site📍 Olomouc The Institute of Molecular and Translational Medicine, Czec… · Tests: Self-sampling by Evalyn Brush, Self sampling by Evalyn Brush home or in GP´s clinic Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT04422366Phase 31 site📍 Liuzhou Shanghai Bovax Biotechnology Co., Ltd. · Tests: 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha), GARD… Global Burden Estimation of Human Papillomavirus (GLOBE-HPV) NCT06129253n/a8 sites📍 Dhaka📍 Kinshasa📍 Ho International Vaccine Institute · Tests: Urine Sample Collection, Self-collected Vaginal Swab, Blood Samples Comparative Self-collection for Cervical Cancer Screening Pivotal Study NCT07758140NA11 sites📍 Phoenix📍 Sherman Oaks📍 Lake Worth Mel Mont Medical · Tests: Mia by XytoTest, Rovers Cervex-Brush Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts NCT05291845Phase 21 site📍 Zagazig Zagazig University · Tests: Candida antigen vaccine, Bivalent HPV vaccine Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli) NCT07668271Phase 41 site📍 Zhangping Xiamen Innovax Biotech Co., Ltd · Tests: 9-valent HPV vaccine (Cecolin 9) PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia NCT07454915Phase 210 sites📍 The Bronx📍 Kaohsiung📍 Taichung PapiVax Biotech, Inc. · Tests: PVX4 Combination Product, Placebo Control Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe NCT07645352NA1 site📍 Harare Fred Hutchinson Cancer Center · Tests: Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes Multiple Human Papillomavirus Infections in the Development of CIN NCT06862102n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia · Tests: HPV vaccine Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination NCT07407569Phase 23 sites📍 Antwerp📍 Ghent📍 Leuven Universiteit Antwerpen · Tests: Gardasil 9 (2 dose regimen) Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir NCT07448844Phase 42 sites📍 Rawalpindi📍 Islamabad Riphah International University · Tests: Intralesional Acyclovir, Intralesional Vitamin D3 The Women's Screening and Self-Testing Program (PROMETA) Study NCT06810739NA1 site📍 Maputo Tulane University · Tests: HPV DNA testing be self-collected vaginal swab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy